drugset / Trial / NCT02867358

A Clinical Trial of KT07 Capsule in the U.S.A

NCT02867358 ↗

Phase 2 Completed 391 enrolled Yiling Pharmaceutical Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate clinical efficacy of KT07 capsule in alleviation of fever and other symptoms including nasal congestion, sore throat, cough, aches and pains, fatigue, headache, chills or sweats in subjects with acute uncomplicated influenza.

Timeline

Start
2016-09
Primary completion
2020-07-31
Completion
2020-07-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator KT07 Unknown 4 unknown —
Comparator KT07 Unknown 6 unknown —

Indications